1 | 2% sodium chondroitin sulfate | - | - | - | - | 1件: 226 226 💬
|
2 | 40MG triamcinolone injections IN THE bladder | - | - | - | - | 1件: 226 226 💬
|
3 | 5% lidocaine/5 MG/ML 0.02% estradiol compound cream | - | - | - | - | 1件: 226 226 💬
|
4 | Adalimumab | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 18件: 19 19, 37, 40, 41, 46, 55, 56, 84, 96, 97, 107, 160, 164, 222, 226, 269, 270, 271 💬
|
5 | AGN 203818 | - | - | - | - | 1件: 226 226 💬
|
6 | Alkalinized lidocaine-heparin | - | - | - | - | 1件: 226 226 💬
|
7 | Allorx | - | - | - | - | 8件: 2 2, 13, 46, 51, 85, 90, 97, 226 💬
|
8 | Amitriptyline | 1件: Amitriptyline Amitriptyline | 2件: Amitriptyline hydrochloride
Amitriptyline hydrochloride
,
Amitriptyline
💬
| 2件: SLC6A2 SLC6A2, SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 226 226, 299 💬
|
9 | Amitriptyline/gabapentin | 1件: Amitriptyline Amitriptyline | 2件: Amitriptyline hydrochloride
Amitriptyline hydrochloride
,
Amitriptyline
💬
| 2件: SLC6A2 SLC6A2, SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 226 226 💬
|
10 | AQX-1125 | 1件: AQX-1125 AQX-1125 | - | - | - | 1件: 226 226 💬
|
11 | AQX-1125 100 MG | 1件: AQX-1125 AQX-1125 | - | - | - | 1件: 226 226 💬
|
12 | AQX-1125 200 MG | 1件: AQX-1125 AQX-1125 | - | - | - | 1件: 226 226 💬
|
13 | ASP3652 | - | - | - | - | 1件: 226 226 💬
|
14 | ASP6294 | - | - | - | - | 1件: 226 226 💬
|
15 | Atogepant | 1件: Atogepant Atogepant | 1件: Atogepant
Atogepant
💬
| 1件: CALCRL CALCRL 💬
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction 💬 | 1件: 226 226 💬
|
16 | Behavioral health consultation/therapy | - | - | - | - | 1件: 226 226 💬
|
17 | Bladder instillation | - | - | - | - | 1件: 226 226 💬
|
18 | Bladder instillation with heparin/ lidocaine | - | - | - | - | 1件: 226 226 💬
|
19 | Bladder instillation with triamcinolone acetonide | - | - | - | - | 1件: 226 226 💬
|
20 | Bladder instillation without triamcinolone acetonide | - | - | - | - | 1件: 226 226 💬
|
21 | Bladder instillations | - | - | - | - | 1件: 226 226 💬
|
22 | Bladder tissue OF interstitial cystitis and normal bladder tissue | - | - | - | - | 1件: 226 226 💬
|
23 | Botox | 1件: Botulinum toxin type A Botulinum toxin type A | 2件: Botulinum toxin type A
Botulinum toxin type A
,
Prabotulinumtoxin A
💬
| 1件: SNAP25 SNAP25 💬
| 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 5件: 6 6, 13, 36, 149, 226 💬
|
24 | Botox 100U IN normal saline | - | - | - | - | 1件: 226 226 💬
|
25 | Botox 200U IN normal saline | - | - | - | - | 1件: 226 226 💬
|
26 | Botulinum toxin A | 1件: Botulinum toxin type A Botulinum toxin type A | 2件: Botulinum toxin type A
Botulinum toxin type A
,
Prabotulinumtoxin A
💬
| 1件: SNAP25 SNAP25 💬
| 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 4件: 13 13, 51, 149, 226 💬
|
27 | Buckwheat | 1件: Buckwheat Buckwheat | - | - | - | 1件: 226 226 💬
|
28 | Bupivacaine | 1件: Bupivacaine Bupivacaine | 2件: Bupivacaine hydrochloride
Bupivacaine hydrochloride
,
Bupivacaine
💬
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬
| 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 3件: 70 70, 168, 226 💬
|
29 | Cannabidiol vaginal suppository | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 226 226 💬
|
30 | Capsaicin | 1件: Capsaicin Capsaicin | 1件: Capsaicin
Capsaicin
💬
| 1件: TRPV1 TRPV1 💬
| 2件: Inflammatory mediator regulation of TRP channels Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 4件: 2 2, 6, 86, 226 💬
|
31 | Cascade | 1件: Flufenoxuron Flufenoxuron | - | - | - | 1件: 226 226 💬
|
32 | Certolizumab pegol | 1件: Certolizumab pegol Certolizumab pegol | 1件: Certolizumab pegol
Certolizumab pegol
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 7件: 37 37, 46, 49, 96, 107, 226, 271 💬
|
33 | Ciclosporin | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 12件: 26 26, 46, 49, 50, 53, 55, 60, 61, 97, 222, 226, 269 💬
|
34 | Ciklosporin | - | - | - | - | 1件: 226 226 💬
|
35 | Clarix FLO | - | - | - | - | 1件: 226 226 💬
|
36 | Cyclosporine | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 28件: 11 11, 28, 40, 41, 42, 45, 46, 49, 50, 53, 56, 60, 61, 62, 63, 64, 65, 97, 107, 162, 164, 222, 226, 228, 283, 284, 285, 302 💬
|
37 | Desert harvest aloe vera capsules | - | - | - | - | 1件: 226 226 💬
|
38 | Dexmedetomidine | 1件: Dexmedetomidine Dexmedetomidine | 2件: Dexmedetomidine
Dexmedetomidine
,
Dexmedetomidine hydrochloride
💬
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| 4件: Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 15件: 2 2, 4, 6, 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
|
39 | Dextrose | 1件: Dextrose, unspecified form Dextrose, unspecified form | 2件: Dextrose
Dextrose
,
Glucose, liquid
💬
| - | - | 4件: 56 56, 60, 201, 226 💬
|
40 | Dimethyl sulfoxide | 1件: Dimethyl sulfoxide Dimethyl sulfoxide | 1件: Dimethyl sulfoxide
Dimethyl sulfoxide
💬
| - | - | 1件: 226 226 💬
|
41 | Dmso | 1件: Dimethyl sulfoxide Dimethyl sulfoxide | 1件: Dimethyl sulfoxide
Dimethyl sulfoxide
💬
| - | - | 1件: 226 226 💬
|
42 | Dmso cocktail | 1件: Dimethyl sulfoxide Dimethyl sulfoxide | 1件: Dimethyl sulfoxide
Dimethyl sulfoxide
💬
| - | - | 1件: 226 226 💬
|
43 | Eptinezumab | 1件: Eptinezumab Eptinezumab | 1件: Eptinezumab
Eptinezumab
💬
| 1件: CALC CALC 💬
| 3件: Hormone signaling Hormone signaling, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction 💬 | 1件: 226 226 💬
|
44 | ERB-041 | - | - | - | - | 3件: 46 46, 96, 226 💬
|
45 | Erenumab | 1件: Erenumab Erenumab | 1件: Erenumab
Erenumab
💬
| 1件: CALCRL CALCRL 💬
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction 💬 | 1件: 226 226 💬
|
46 | Ferumoxytol | 1件: Ferumoxytol Ferumoxytol | 1件: Ferumoxytol
Ferumoxytol
💬
| - | - | 2件: 13 13, 226 💬
|
47 | Flavoxate | 1件: Flavoxate Flavoxate | 2件: Flavoxate hydrochloride
Flavoxate hydrochloride
,
Flavoxate
💬
| 16件: PDE1 PDE1, PDE1, PDE1, PDE10, PDE11, PDE2A, PDE3A, PDE3B, PDE4, PDE4, PDE4, PDE4, PDE7, PDE7, PDE8, PDE8 💬
| 17件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 226 226 💬
|
48 | Fospropofol (lusedra®) 10 | 1件: Fospropofol Fospropofol | 1件: Fospropofol disodium
Fospropofol disodium
💬
| 16件: GABRA GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬
| 8件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 226 226 💬
|
49 | Fospropofol (lusedra®) 6.5 | 1件: Fospropofol Fospropofol | 1件: Fospropofol disodium
Fospropofol disodium
💬
| 16件: GABRA GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬
| 8件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 226 226 💬
|
50 | Fremanezumab | 1件: Fremanezumab Fremanezumab | 1件: Fremanezumab
Fremanezumab
💬
| 1件: CALC CALC 💬
| 3件: Hormone signaling Hormone signaling, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction 💬 | 2件: 124 124, 226 💬
|
51 | Gadobutrol | 1件: Gadobutrol Gadobutrol | 1件: Gadobutrol
Gadobutrol
💬
| - | - | 4件: 13 13, 22, 46, 226 💬
|
52 | Galcanezumab | 1件: Galcanezumab Galcanezumab | 1件: Galcanezumab
Galcanezumab
💬
| 1件: CALC CALC 💬
| 3件: Hormone signaling Hormone signaling, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction 💬 | 1件: 226 226 💬
|
53 | Gefapixant | 1件: Gefapixant Gefapixant | 2件: Gefapixant
Gefapixant
,
Gefapixant citrate
💬
| 1件: P2RX3 P2RX3 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction 💬 | 2件: 85 85, 226 💬
|
54 | Glucose | 1件: Dextrose, unspecified form Dextrose, unspecified form | 2件: Dextrose
Dextrose
,
Glucose, liquid
💬
| - | - | 9件: 6 6, 13, 66, 77, 96, 97, 226, 254, 299 💬
|
55 | Glycine | 1件: Glycine Glycine | 1件: Glycine
Glycine
💬
| - | - | 6件: 35 35, 60, 226, 247, 299, 340 💬
|
56 | Gralise | - | - | - | - | 2件: 97 97, 226 💬
|
57 | Heparin | 1件: Heparin Heparin | 2件: Heparin sodium
Heparin sodium
,
Heparin calcium
💬
| 1件: SERPINC1 SERPINC1 💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 7件: 47 47, 60, 65, 70, 84, 107, 226 💬
|
58 | Heparin & alkalinized lidocaine bladder instillation | 1件: Heparin Heparin | 2件: Heparin sodium
Heparin sodium
,
Heparin calcium
💬
| 1件: SERPINC1 SERPINC1 💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 226 226 💬
|
59 | High density surface electromyographic, precision botulinum neurotoxin injection guidance medical device | - | - | - | - | 1件: 226 226 💬
|
60 | Hyaluronic acid and chondroitin sulfate | 1件: Hyaluronic acid Hyaluronic acid | 2件: Hyaluronate sodium
Hyaluronate sodium
,
Hyaluronic acid
💬
| - | - | 1件: 226 226 💬
|
61 | Hyaluronic acid/chondroitin sulfate | 1件: Hyaluronic acid Hyaluronic acid | 2件: Hyaluronate sodium
Hyaluronate sodium
,
Hyaluronic acid
💬
| - | - | 1件: 226 226 💬
|
62 | Hydrogen | 1件: Hydrogen Hydrogen | - | - | - | 6件: 5 5, 6, 17, 97, 226, 288 💬
|
63 | Hyperbaric oxygen therapy | - | - | - | - | 3件: 90 90, 97, 226 💬
|
64 | IC cocktail | - | - | - | - | 1件: 226 226 💬
|
65 | Immunonutrition | - | - | - | - | 2件: 96 96, 226 💬
|
66 | Inactive drug | - | - | - | - | 1件: 226 226 💬
|
67 | Injections ON posterior bladder wall excluding THE trigone | - | - | - | - | 1件: 226 226 💬
|
68 | Injections upper aspect OF trigone OF urinary bladder | - | - | - | - | 1件: 226 226 💬
|
69 | Interferential current | - | - | - | - | 1件: 226 226 💬
|
70 | Interferon | - | - | - | - | 1件: 226 226 💬
|
71 | Intermittent exposure TO oxygen VIA ORO-nasal mask | - | - | - | - | 1件: 226 226 💬
|
72 | Intravesical onabotulinumtoxina injection | - | - | - | - | 1件: 226 226 💬
|
73 | Intravesical ozone therapy | - | - | - | - | 1件: 226 226 💬
|
74 | IW-3300 rectal foam | - | - | - | - | 1件: 226 226 💬
|
75 | JNJ-42160443 | - | - | - | - | 1件: 226 226 💬
|
76 | Ketorolac tromethamine | 1件: Ketorolac Ketorolac | 2件: Ketorolac tromethamine
Ketorolac tromethamine
,
Ketorolac
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 226 226 💬
|
77 | Lidocaine | 1件: Lidocaine Lidocaine | 3件: Lidocaine
Lidocaine
,
Lidocaine hydrochloride
,
Lidocaine hydrochloride monohydrate
💬
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬
| 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 10件: 6 6, 13, 22, 46, 86, 107, 168, 226, 231, 256 💬
|
78 | Liposome encapsulated BONT-A | - | - | - | - | 1件: 226 226 💬
|
79 | Liposomes | - | - | - | - | 1件: 226 226 💬
|
80 | Liris 400 MG | - | - | - | - | 1件: 226 226 💬
|
81 | Liris LOW dose and liris high dose | - | - | - | - | 1件: 226 226 💬
|
82 | Liris® 400 MG | - | - | - | - | 1件: 226 226 💬
|
83 | LOW-dose naltrexone | - | - | - | - | 1件: 226 226 💬
|
84 | LP-08 20MG | - | - | - | - | 1件: 226 226 💬
|
85 | LP-08 80MG | - | - | - | - | 1件: 226 226 💬
|
86 | Methenamine | 1件: Methenamine Methenamine | 3件: Methenamine
Methenamine
,
Methenamine hippurate
,
Methenamine mandelate
💬
| - | - | 1件: 226 226 💬
|
87 | Metoprolol tartrate oral tablet | 1件: Metoprolol Metoprolol | 4件: Metoprolol tartrate
Metoprolol tartrate
,
Metoprolol succinate
,
Metoprolol
,
Metoprolol fumarate
💬
| 1件: ADRB1 ADRB1 💬
| 13件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 226 226 💬
|
88 | Mirabegron | 1件: Mirabegron Mirabegron | 1件: Mirabegron
Mirabegron
💬
| 1件: ADRB3 ADRB3 💬
| 9件: Calcium signaling pathway Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cGMP-PKG signaling pathway 💬 | 4件: 6 6, 13, 53, 226 💬
|
89 | MMF | - | - | - | - | 15件: 13 13, 35, 40, 46, 49, 50, 51, 60, 65, 66, 84, 107, 222, 224, 226 💬
|
90 | MN-001 BID | - | - | - | - | 1件: 226 226 💬
|
91 | MR-MC-01 | - | - | - | - | 1件: 226 226 💬
|
92 | Multimodal bundle drugs | - | - | - | - | 1件: 226 226 💬
|
93 | Mycophenolate mofetil | 2件: Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | 4件: Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
,
Mycophenolate sodium
,
Mycophenolic acid
💬
| 2件: IMPDH IMPDH, IMPDH 💬
| 2件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | 32件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 46, 49, 51, 53, 60, 62, 63, 65, 66, 93, 95, 96, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬
|
94 | Naloxone hydrochloride | 1件: Naloxone Naloxone | 3件: Naloxone hydrochloride
Naloxone hydrochloride
,
Naloxone
,
Naloxone hydrochloride dihydrate
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 226 226 💬
|
95 | Naltrexone | 1件: Naltrexone Naltrexone | 2件: Naltrexone hydrochloride
Naltrexone hydrochloride
,
Naltrexone
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 5件: 6 6, 10, 13, 96, 226 💬
|
96 | NO intervention- observational SUB-study | - | - | - | - | 1件: 226 226 💬
|
97 | Normal saline | - | - | - | - | 20件: 6 6, 13, 17, 22, 36, 46, 49, 60, 70, 94, 96, 97, 210, 211, 222, 226, 276, 280, 296, 299 💬
|
98 | Normal saline instillation | - | - | - | - | 1件: 226 226 💬
|
99 | Nortriptyline | 1件: Nortriptyline Nortriptyline | 2件: Nortriptyline hydrochloride
Nortriptyline hydrochloride
,
Nortriptyline
💬
| 2件: SLC6A2 SLC6A2, SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 6 6, 226 💬
|
100 | Omalizumab | 1件: Omalizumab Omalizumab | 1件: Omalizumab
Omalizumab
💬
| 1件: FCER1A FCER1A 💬
| 4件: Asthma Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬 | 7件: 46 46, 53, 65, 98, 162, 226, 299 💬
|
101 | Onabotulinum toxin A | - | - | - | - | 1件: 226 226 💬
|
102 | Onabotulinumtoxin A | - | - | - | - | 2件: 51 51, 226 💬
|
103 | ONO-1110 | - | - | - | - | 1件: 226 226 💬
|
104 | Operative cystoscopy | - | - | - | - | 1件: 226 226 💬
|
105 | OXN 10/5 MG PR | - | - | - | - | 1件: 226 226 💬
|
106 | OXN 20/10 MG PR | - | - | - | - | 1件: 226 226 💬
|
107 | OXN 5/2.5 MG PR | - | - | - | - | 1件: 226 226 💬
|
108 | Oxycodone hydrochloride | 1件: Oxycodone Oxycodone | 3件: Oxycodone hydrochloride
Oxycodone hydrochloride
,
Oxycodone terephthalate
,
Oxycodone
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 4件: 6 6, 70, 226, 298 💬
|
109 | Oxycodone naloxone prolonged release tablets | 1件: Oxycodone Oxycodone | 3件: Oxycodone hydrochloride
Oxycodone hydrochloride
,
Oxycodone terephthalate
,
Oxycodone
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 226 226 💬
|
110 | Oxycodone/naloxone prolonged release T | 2件: Naloxone Naloxone, Oxycodone | 6件: Oxycodone hydrochloride
Oxycodone hydrochloride
,
Naloxone hydrochloride
,
Oxycodone terephthalate
,
Oxycodone
,
Naloxone
,
Naloxone hydrochloride dihydrate
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 226 226 💬
|
111 | Oxycodone/naloxone prolonged release tablets 10/5 MG | 2件: Naloxone Naloxone, Oxycodone | 6件: Oxycodone hydrochloride
Oxycodone hydrochloride
,
Naloxone hydrochloride
,
Oxycodone terephthalate
,
Oxycodone
,
Naloxone
,
Naloxone hydrochloride dihydrate
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 226 226 💬
|
112 | Oxycodone/naloxone prolonged release tablets 20/10 MG | 2件: Naloxone Naloxone, Oxycodone | 6件: Oxycodone hydrochloride
Oxycodone hydrochloride
,
Naloxone hydrochloride
,
Oxycodone terephthalate
,
Oxycodone
,
Naloxone
,
Naloxone hydrochloride dihydrate
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 226 226 💬
|
113 | Oxycodone/naloxone prolonged release tablets 5/2.5 MG | 2件: Naloxone Naloxone, Oxycodone | 6件: Oxycodone hydrochloride
Oxycodone hydrochloride
,
Naloxone hydrochloride
,
Oxycodone terephthalate
,
Oxycodone
,
Naloxone
,
Naloxone hydrochloride dihydrate
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 226 226 💬
|
114 | Oxytocin | 1件: Oxytocin Oxytocin | 1件: Oxytocin
Oxytocin
💬
| 1件: OXTR OXTR 💬
| 5件: Calcium signaling pathway Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | 4件: 127 127, 168, 193, 226 💬
|
115 | Ozone | 1件: Ozone Ozone | - | - | - | 4件: 49 49, 51, 70, 226 💬
|
116 | PD 0299685 | - | - | - | - | 1件: 226 226 💬
|
117 | PD 0299685 AT 15MG BID | - | - | - | - | 1件: 226 226 💬
|
118 | PD 0299685 AT 30MG BID | - | - | - | - | 1件: 226 226 💬
|
119 | PD-0299685 | 1件: PD-0299685 PD-0299685 | - | - | - | 1件: 226 226 💬
|
120 | Pelvic floor physical therapy | - | - | - | - | 1件: 226 226 💬
|
121 | Pentosan polysulfate sodium 100 MG | 1件: Pentosan polysulfate Pentosan polysulfate | 1件: Pentosan polysulfate sodium
Pentosan polysulfate sodium
💬
| - | - | 1件: 226 226 💬
|
122 | PF-04383119 | - | - | - | - | 1件: 226 226 💬
|
123 | Platelet enriched plasma | - | - | - | - | 1件: 226 226 💬
|
124 | Platelet-rich plasma | - | - | - | - | 1件: 226 226 💬
|
125 | Prograf | 1件: Tacrolimus Tacrolimus | 2件: Tacrolimus
Tacrolimus
,
Tacrolimus
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 60 60, 222, 226 💬
|
126 | Propiverine hydrochloride | 1件: Propiverine Propiverine | 2件: Propiverine hydrochloride
Propiverine hydrochloride
,
Propiverine
💬
| 9件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬
| 44件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Regulation of actin cytoskeleton, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 226 226 💬
|
127 | PRP | - | - | - | - | 2件: 90 90, 226 💬
|
128 | Rimegepant | 1件: Rimegepant Rimegepant | 2件: Rimegepant
Rimegepant
,
Rimegepant sulfate
💬
| 1件: CALCRL CALCRL 💬
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction 💬 | 1件: 226 226 💬
|
129 | Rimso 50 | - | - | - | - | 1件: 226 226 💬
|
130 | RN624, RI624 | - | - | - | - | 1件: 226 226 💬
|
131 | Saline AS A nasal spray | - | - | - | - | 1件: 226 226 💬
|
132 | Sandimmun | - | - | - | - | 2件: 97 97, 226 💬
|
133 | Sandimmun neoral | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 4件: 54 54, 60, 97, 226 💬
|
134 | Sham cystoscopy procedure | - | - | - | - | 1件: 226 226 💬
|
135 | SI-722 | - | - | - | - | 1件: 226 226 💬
|
136 | Sildenafil | 1件: Sildenafil Sildenafil | 2件: Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 14件: 6 6, 46, 51, 85, 86, 113, 210, 211, 212, 225, 226, 278, 294, 299 💬
|
137 | Sodium bicarbonate | 1件: Sodium bicarbonate Sodium bicarbonate | 1件: Sodium bicarbonate
Sodium bicarbonate
💬
| - | - | 3件: 97 97, 226, 299 💬
|
138 | Sodium chloride injection | 1件: Sodium chloride Sodium chloride | 1件: Sodium chloride
Sodium chloride
💬
| - | - | 1件: 226 226 💬
|
139 | Sodium hyaluronate | 1件: Hyaluronic acid Hyaluronic acid | 2件: Hyaluronate sodium
Hyaluronate sodium
,
Hyaluronic acid
💬
| - | - | 3件: 53 53, 97, 226 💬
|
140 | Suplatast tosilate | 1件: Suplatast Suplatast | 1件: Suplatast tosilate
Suplatast tosilate
💬
| - | - | 1件: 226 226 💬
|
141 | Tacrolimus | 1件: Tacrolimus Tacrolimus | 2件: Tacrolimus
Tacrolimus
,
Tacrolimus
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 31件: 2 2, 6, 11, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286 💬
|
142 | Tanezumab | 1件: Tanezumab Tanezumab | 1件: Tanezumab
Tanezumab
💬
| 1件: NGFB NGFB 💬
| 9件: Apoptosis Apoptosis, Calcium signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 2件: 226 226, 298 💬
|
143 | Targinact 10 MG/5 MG prolonged-release tablets | - | - | - | - | 2件: 6 6, 226 💬
|
144 | Targinact 20MG/10 MG prolonged-release tablets | - | - | - | - | 1件: 226 226 💬
|
145 | Targinact 5MG/2.5 MG prolonged-release tablets | - | - | - | - | 1件: 226 226 💬
|
146 | Tramadol | 1件: Tramadol Tramadol | 2件: Tramadol hydrochloride
Tramadol hydrochloride
,
Tramadol
💬
| 1件: OPRM1 OPRM1 💬
| 5件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 3件: 46 46, 70, 226 💬
|
147 | Transvaginal botulinum toxin A (BTA) injection | - | - | - | - | 1件: 226 226 💬
|
148 | Triamcinolone | 1件: Triamcinolone Triamcinolone | 4件: Triamcinolone
Triamcinolone
,
Triamcinolone acetonide
,
Triamcinolone diacetate
,
Triamcinolone hexacetonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 6件: 46 46, 53, 90, 96, 226, 298 💬
|
149 | TTI-1612 | - | - | - | - | 1件: 226 226 💬
|
150 | Ubrogepant | 1件: Ubrogepant Ubrogepant | 1件: Ubrogepant
Ubrogepant
💬
| 1件: CALCRL CALCRL 💬
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction 💬 | 1件: 226 226 💬
|
151 | URG101 | - | - | - | - | 1件: 226 226 💬
|
152 | Urodynamic study | - | - | - | - | 1件: 226 226 💬
|
153 | Usual urogynecologic care | - | - | - | - | 1件: 226 226 💬
|
154 | V117957 | - | - | - | - | 1件: 226 226 💬
|
155 | Vaginal estrogen | - | - | - | - | 1件: 226 226 💬
|
156 | VNX001 | - | - | - | - | 1件: 226 226 💬
|
157 | Water | 1件: Water Water | 1件: Water
Water
💬
| - | - | 25件: 2 2, 5, 6, 13, 17, 19, 22, 46, 51, 53, 56, 57, 63, 64, 66, 67, 85, 96, 97, 206, 226, 230, 274, 278, 299 💬
|
158 | YM672 | - | - | - | - | 1件: 226 226 💬
|